AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023-2024

J Assoc Med Microbiol Infect Dis Can. 2024 Jan 16;8(4):245-252. doi: 10.3138/jammi-2023-12-07. eCollection 2024 Jan.
No abstract available

Keywords: COVID-19; SARS-coV-2; SRAS-CoV-2; anti-inflammatory medications; anti-microbial stewardship; anti-viral therapy; gestion des antimicrobiens; médicaments anti-inflammatoires; recommandations thérapeutiques; traitement antiviral; treatment recommendations.